Alport Research Hub Symposium: From Bench to BedsideÂ
Discover key insights from the third Alport Research Hub Symposium and learn how Medpace's expertise advances rare nephrology research.
Behind the Breakthroughs: Rare Disease Q&A with Lauren Shannon
In this Q&A, Lauren Shannon discusses her experience and the role that Medpace plays in advancing innovative rare disease therapies.
Q&A With New Medical Expert: Dr. Jack Bleesing, MD, PhD
Medpace is proud to welcome Dr. Jack Bleesing, an accomplished immunologist and board-certified physician-scientist, with 20+ years of experience to...
[On-Demand Webinar] 3 Key Trends Transforming the Future of Rare Disease Clinical Development
Rare disease clinical development is undergoing rapid transformation, driven by scientific innovation, evolving regulatory frameworks, and the need for more flexible, patient-centric trial designs.
[On-Demand Webinar] Bridging Borders: Strategies for Successful Cross-Border Participation in Global Rare Disease Clinical Trials
Watch the on-demand Rare Disease Day webinar to explore strategies for cross-border patient enrollment and retention.
Medpace Expands Rare Disease & Metabolic Medical Leadership Team
Medpace is pleased to announce the addition of a new rare disease and metabolic expert, Dr. Loren Peña, to the medical leadership team.
[On-Demand Webinar] A Collaborative Approach to Advancing Access and Equity in Rare Disease Clinical Trials
Watch the on-demand webinar from Rare Disease Day 2024 to join the discussion with clinical trial experts on a collaborative approach to patient-friendly trials in…
[Upcoming Webinar] Successful Approaches from Rare Disease and Cellular & Gene Therapy Product Approvals
Register now for the Rare Disease Day webinar to join the discussion with Medpace experts on successful approaches to achieve cellular and gene therapy approvals…
[Webinar] The Complexities of Pediatric Rare Disease Trials: Regulatory and Operational Strategies for Success
In this on-demand webinar, Medpace experts share the operational and regulatory challenges associated with pediatric rare disease clinical trials.
New White Paper: The Intersection of Rare Diseases and Advanced Therapies and What it Means for Clinical Development
Read the press release for the latest whitepaper on advanced therapies and rare diseases published by Xtalks and Medpace.